Cargando…

Resolvin D1, therapeutic target in acute respiratory distress syndrome

Acute lung injury (ALI), or its more severe form, acute respiratory distress syndrome (ARDS), is a disease with high mortality and is a serious challenge facing the World Health Organization because there is no specific treatment. The excessive and prolonged immune response is the hallmark of this d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Molaei, Emad, Molaei, Ali, Hayes, A. Wallace, Karimi, Gholamreza
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V. 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8464084/ https://www.ncbi.nlm.nih.gov/pubmed/34582846 http://dx.doi.org/10.1016/j.ejphar.2021.174527

Ejemplares similares

Nephroprotective activity of natural products against chemical toxicants: The role of Nrf2/ARE signaling pathway
por: Molaei, Emad, et al.
Publicado: (2021)

Therapeutic targeting of metabolic alterations in acute respiratory distress syndrome
por: Robinson, Matthew John, et al.
Publicado: (2020)

Carbon quantum dots and their biomedical and therapeutic applications: a review
por: Molaei, Mohammad Jafar
Publicado: (2019)

Resolvin D1 and Aspirin-Triggered Resolvin D1 Regulate Histamine-stimulated Conjunctival Goblet Cell Secretion
por: Li, Dayu, et al.
Publicado: (2013)

Identification of potential biomarkers and therapeutic targets for posttraumatic acute respiratory distress syndrome
por: Qi, Peng, et al.
Publicado: (2023)

Acute Respiratory Distress Syndrome: Pathophysiology and Therapeutic Options
por: Pierrakos, Charalampos, et al.
Publicado: (2012)

RNAi therapeutic strategies for acute respiratory distress syndrome
por: Jagrosse, Melissa L., et al.
Publicado: (2019)

Oxygenation target in acute respiratory distress syndrome
por: Capellier, Gilles, et al.
Publicado: (2023)

Identification of Resolvin D1 and Protectin D1 as Potential Therapeutic Agents for Treating Kidney Stones
por: Wang, Bohan, et al.
Publicado: (2022)

Effect of Fish Oil vs. Resolvin D1, E1, Methyl Esters of Resolvins D1 or D2 on Diabetic Peripheral Neuropathy
por: Obrosov, Alexander, et al.
Publicado: (2017)

Using Dictyostelium to Develop Therapeutics for Acute Respiratory Distress Syndrome
por: Kirolos, Sara A., et al.
Publicado: (2021)

Respiratory drive in the acute respiratory distress syndrome: pathophysiology, monitoring, and therapeutic interventions
por: Spinelli, Elena, et al.
Publicado: (2020)

Is there any association between vitamin D levels and polycystic ovary syndrome (PCOS) phenotypes?
por: Eftekhar, Maryam, et al.
Publicado: (2019)

Targeting the D Series Resolvin Receptor System for the Treatment of Osteoarthritis Pain
por: Huang, Junting, et al.
Publicado: (2017)

Predictive modeling of aspirin‐triggered resolvin D1 pharmacokinetics for the study of Sjögren's syndrome
por: Yellepeddi, Venkata Kashyap, et al.
Publicado: (2019)

Extracorporeal life support for acute respiratory distress syndromes
por: Hayes, Don, et al.
Publicado: (2013)

Plausibility of therapeutic effects of Rho kinase inhibitors against Severe Acute Respiratory Syndrome Coronavirus 2 (COVID-19)
por: Abedi, Farshad, et al.
Publicado: (2020)

Acute respiratory distress syndrome.
por: Lunn, J. J., et al.
Publicado: (1998)

Acute respiratory distress syndrome
por: Matthay, Michael A., et al.
Publicado: (2019)

Acute respiratory distress syndrome
por: Chen, Hsing I., et al.
Publicado: (2003)

Acute Respiratory Distress Syndrome
por: Ahmad, Fawaz, et al.
Publicado: (2018)

Acute respiratory distress syndrome
por: Sweeney, Rob Mac, et al.
Publicado: (2016)

Acute Respiratory Distress Syndrome
por: Gragossian, Alin, et al.
Publicado: (2022)

Acute Respiratory Distress Syndrome
por: Adams, Claire E., et al.
Publicado: (2022)

Acute respiratory distress syndrome
por: Meyer, Nuala J, et al.
Publicado: (2021)

Acute respiratory distress syndrome
por: Confalonieri, Marco, et al.
Publicado: (2017)

Acute Respiratory Distress Syndrome
por: Matthay, Michael A., et al.
Publicado: (2021)

Resolvin D1 drives establishment of Leishmania amazonensis infection
por: Malta-Santos, Hayna, et al.
Publicado: (2017)

Liponucleotides: Promises and Unknowns as Novel Therapeutics for Acute Respiratory Distress Syndrome
por: Hung, Chi F., et al.
Publicado: (2021)

Resolvin D1 and Resolvin E1 Promote the Resolution of Allergic Airway Inflammation via Shared and Distinct Molecular Counter-Regulatory Pathways
por: Levy, Bruce D.
Publicado: (2012)

Complement as a vital nexus of the pathobiological connectome for acute respiratory distress syndrome: An emerging therapeutic target
por: Yang, Zhangsheng, et al.
Publicado: (2023)

Urtica dioica Agglutinin: A plant protein candidate for inhibition of SARS-COV-2 receptor-binding domain for control of Covid19 Infection
por: Sabzian-Molaei, Fatemeh, et al.
Publicado: (2022)

Does vitamin D serum level affect prognosis of COVID-19 patients?
por: Nasiri, Maryam, et al.
Publicado: (2021)

Resolvin D1 attenuates sepsis induced acute kidney injury targeting mitochondria and NF-κB signaling pathway
por: Wang, Liya, et al.
Publicado: (2022)

Association of the resolvin precursor 17-HDHA, but not D- or E- series resolvins, with heat pain sensitivity and osteoarthritis pain in humans
por: Valdes, Ana M., et al.
Publicado: (2017)

Mesenchymal stem cells - a promising therapy for Acute Respiratory Distress Syndrome
por: Hayes, Mairead, et al.
Publicado: (2012)

Resolvins and inflammatory pain
por: Sommer, Claudia, et al.
Publicado: (2011)

Resolvins on the way to resolution
por: Ward, Peter A.
Publicado: (2015)

Acute Respiratory Distress Syndrome in Lemierre's Syndrome
por: Hein, Paul N., et al.
Publicado: (2014)

Update in acute respiratory distress syndrome
por: Koh, Younsuck
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ua3fgp9485uhfmnp5kc3mhg30m